An Intraoperative $\beta^-$ Detecting Probe For Radio-Guided Surgery in
  Tumour Resection by Russomando, Andrea et al.
An Intraoperative β− Detecting Probe For
Radio-Guided Surgery in Tumour Resection
Andrea Russomando∗†‡, Fabio Bellini∗†, Valerio Bocci†, Giacomo Chiodi†, Francesco Collamati†§,
Erika De Lucia¶, Raffaella Donnarumma∗, Riccardo Faccini∗†, Carlo Mancini-Terracciano∗†, Michela Marafini†‖,
Riccardo Paramatti†, Vincenzo Patera†§‖, Luigi Recchia†, Alessio Sarti§¶, Adalberto Sciubba†§‖,
Elena Solfaroli Camillocci∗†, Cecilia Voena† and Silvio Morganti†
Abstract—The development of the β− based radio-guided
surgery aims to extend the technique to those tumours where
surgery is the only possible treatment and the assessment of the
resection would most profit from the low background around the
lesion, as for brain tumours. Feasibility studies on meningioma,
glioma, and neuroendocrine tumors already estimated the poten-
tiality of this new treatment. To validate the technique, prototypes
of the intraoperative probe required by the technique to detect β−
radiation have been developed. This paper discusses the design
details of the device and the tests performed in laboratory. In such
tests particular care has to be taken to reproduce the surgical
field conditions. The innovative technique to produce specific
phantoms and the dedicated testing protocols is described in
detail.
I. INTRODUCTION
THE main advantage of the radio-guided surgery (RGS)technique exploiting β− radiation [1], [2], compared to
the traditional RGS using γ radiation [3], is a more favourable
ratio between the signal coming from the tumor and the rest
of the body. Conversely to the tracers with γ emitters, pure
β− radionuclides emit electrons which penetrate only a few
millimeters of tissue and produce almost no gamma radiation
(the bremsstrahlung contribution above 100 keV being less
than 0.1%) resulting in a very low background on the lesion
signal.
Operating in a low background environment allows the
development of a handy and compact probe which, detecting
particles emitted locally, provides a clearer delineation of mar-
gins of the lesioned tissue. The RGS technique applicability
can therefore be extended also to cases with large uptake of
the tracer from healthy organs next to the lesion, minimizing
the radiotracer activity to be administered. Low exposure of
the medical team is also expected [1].
For this technique to enter in the clinical practice, relevant
clinical cases need to be identified, suitable radio-tracers need
to be developed for them and a detector needs to be designed
and tested for this specific application.
The most relevant clinical cases are those where the RGS
with γ radiation is not applicable because of the presence of
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uptaking organs nearby, for instance cerebral, abdominal and
pediatric tumors.
Fig. 1. Image of the intraoperative β− probe.
Among the existing radio-tracers those that are linked to
pure β− emitters are those used in radio-methabolic treatments
with 90Y, such as Peptide Receptor Radionuclide Therapy [4].
Such tracers are somatostatin analogues (e.g. DOTATOC [5])
and very selective for meningioma [6] and neuroendocrine
tumors (NET) [7]. Our first choice has been indeed to use
meningioma as proof of principle and abdominal NETs as a
first application with clinical relevance. In the case of admin-
istration of 90Y-DOTATOC for meningioma, glioma and NET
we have performed feasibility studies [8], [9] of which the
present paper describes critical ingredients. We are finalizing
the authorizations for the clinical tests. Nonetheless, to extend
this technique beyond NETs, other radio-tracers need to be
considered and we cannot restrict only to pure β− decays.
There is indeed a significant number of nuclides which have
a half-life (τ1/2) compatible with clinical applications and a
limited γ radiation. For instance 186Re has τ1/2 ∼ 90 h and
137 keV photons in only 9% of the cases. To this aim, the
design of the detector needs to take into account the existence
of a γ radiation, albeit limited, and the softer β− spectrum
(endpoint at 1.1 MeV as opposed to 2.3 MeV).
Finally, the requirements on the detecting probe are driven
by the surgical conditions and by the characteristics of the
radio-tracers: the probe needs to be sensitive to residuals as
small as 0.1 ml, benchmark chosen by the sensitivity of the
pre-operative diagnostics; it needs to be directional, i.e. insen-
sitive to radiation from the sides; it needs to have the largest
possible detection efficiency on electrons with the smallest
sensitivity to photons; the smallest is the minimum electron
energy that can be detected, the wider is the applicability of
the technique because it allows for more radio-isotopes to be
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used and because it retains the sensitivity to tumor even if a
thin layer of other tissues or liquids covers it; finally, it needs
to match the security standards for intra-operative use.
In this context, this paper describes the design details of our
first prototype and the test in laboratory of its performances.
Such tests had to be designed to reproduce by means of
phantoms and automated procedures conditions as close as
possible to the surgical environment. The outcome of these
tests were input to the simulations that were used to estimate
the sensitivity of the RGS technique proposed in several
clinical cases [8], [9], studies that are preliminary to the
clinical tests.
II. THE β− INTRAOPERATIVE PROBE
In the first prototype of the intraoperative probe (Fig. 1)
the radiation sensitive element is a scintillator tip made of
commercial poly-crystalline para-terphenyl doped to 0.1% in
mass with diphenylbutadiene [10] manufactured by Detec-
Europe. This material was adopted, after a detailed study [11],
due to its high light yield (∼3 times larger than typical organic
scintillators), negligible hygroscopy, and low density, char-
acteristics that minimize the sensitivity to photons. Different
detector sizes were tested: the best configuration resulted in a
cylinder of 5 mm in diameter and 3 mm in height.
The scintillator tip is shielded from radiation coming from
the sides by a black PVC ring with external diameter of
11 mm. A 10 µm-thick aluminium front-end sheet covers the
detector window to ensure light tightness. This assembly is
mounted on top of an easy-to-handle aluminum cylindrical
body (diameter 8 mm and length 14 cm).
In order to avoid the risk of patients coming into contact
with electrical devices, the scintillation light is guided by four
50 cm long optical fibres outside the probe to a Hamamatsu
H10721-210 photo-multiplier tube (PMT). This photo-sensor
module has an integrated high voltage power supply circuit
requiring an input voltage as low as 5 V, making this device
compatible with the surgical environment. Finally, the read-
out electronics and the logic board are housed in a compact
box that wirelessly connects to a remote monitor to display
the counting rate [12].
III. CHARACTERIZATION OF THE β− INTRAOPERATIVE
PROBE
The characterization of the probe response to β− decays is
performed with two 90Sr sources a point-like one with nominal
activity of ∼370 Bq (point-source) and a 1.6 cm diameter
source with a 2.54 ± 0.15 kBq activity (extended-source).
The 90Sr spectrum is made of two components in secular
equilibrium: the Sr β− decay to 90Y and the subsequent β−
decay of the daughter. The latter component is exactly the one
relevant for the proposed for RGS if 90Y is used.
A. Efficiency
To reduce the required injected activity it is important to
maximize the efficiency. Furthermore, given the fact that even
if we are currently considering 90Y as radionuclide different
emitters will have to be considered in the future, it is important
to know how low in energy the sensitivity of the probe extends.
Therefore, we had to setup an ad-hoc measurement to evaluate
the efficiency as a function of the emitted electron.
To this aim a vertical scan over the extended-source was
performed measuring the rate with both the source and the
probe in water for several distances (Dw) between the two. The
presence of increasing amounts of water dumps the β− energy
spectrum in a way that depends on the energy dependence
of the efficiency. On the other hand, the absolute measured
rate, and in particular the rate measured at contact (zero water
thickness) depends on the absolute efficiency.
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Fig. 3. Probe efficiency as a function of the electron energy (Ein).
To correlate the measured rates with the efficiency a Monte
Carlo (MC) simulation based on FLUKA code [13] was used.
The FLUKA software fully simulates the energy and position
spectrum emitted by the source, the energy deposition in
water and the probe. It also simulates the light emission and
collection with the parameters measured in Ref. [11], returning
the number of photoelectrons reaching the PMT (NPMT ). The
fraction of the electrons that are emitted by the source and
reach the detector is estimated by the fraction of the simulated
electrons that satisfy the condition NPMT > Nthr. It has to
be stressed that this is not an estimate of the minimum number
of photo electrons that are required to have a signal since the
quantum-efficiency needs to be taken into account.
The comparison of this estimate with data allowed to extract
a value of Nthr, in two independent ways. On one side, Nthr
was tuned to match the measured rate in the configuration
where the probe is in contact with the source. The best
compatible threshold value was found to be Nthr = 240. On
the other side, Nthr affects the dependence of the rate with Dw
(see Fig. 2 on the left). A χ2 of agreement in between the data
and MC rate variations between Dw = 7 and Dw = 8.2 mm
was calculated for each value of Nthr. Such χ2 showed a clear
minimum in Nthr = 250 (Fig. 2 on the right).
The two estimates of Nthr are compatible and therefore we
considered the average Nthr = 245. To translate this estimate
in terms of efficiency as a function of energy, we performed
another simulation with the point-source and computed the
ratio of the electron energy spectrum with and without the
requirement NPMT > Nthr. The result is shown in Fig. 3.
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Fig. 2. Left: Dependence of the electron rate as a function of water thickness Dw , in data and in several MC configurations differing by the threshold in
the number of photoelectrons. Right: χ2 of agreement between data and MC (see text) as a function of Nthr (Nthr).
The efficiency raises at energies above 540 keV (energy at
which the curve reaches half of its maximum) and reaches the
high energy plateaux at 70%.
B. Spatial resolution
To study the capability of the probe to reconstruct active
spots, the detector was mounted on a motorized linear actuator
ensuring position accuracy of 1.5 µm and horizontal scans
were performed over the point-source in air.
Fig. 4. Profiles of the point-like Sr-source reconstructed by the probe at
different distances from the source.
An horizontal scan over the point-like Sr-source (Fig. 4)
allowed to estimate the dependence of the spatial resolution
on the distance between the probe tip and the surface. The
reconstructed profiles measured at distances ranging from
350 µm to 1.8 mm are fitted using a Gaussian distribution
obtaining σ between 2.8 and 4.4 mm.
C. Background rejection capability
The usage of pure β− emitting tracers allows to operate
with low radiation background, the residual being mainly
due to photons coming from the Bremsstrahlung radiation
of the electrons penetrating the tissue. The abundance of the
expected Bremsstrahlung radiation in the tissue as a function
of the photon energy is shown in Fig. 5 as computed with
Fig. 5. Energy spectrum (50-2000 keV, 10 keV interval) of 90Y
Bremsstrahlung photons in water.
a simulation of a 90Y source in water [14]. It is important
in any case to ascertain that such radiation does not alter the
locality of the measurement. Conversely, in the case non pure
β− emitters are used, it is important to minimize the sensitivity
to γs.
To this aim, the sensitivity of the probe to photons was mea-
sured using three point-like sources: 133Ba emitting photons
with energy ranging from 80 to 350 keV, 137Cs with gamma
emission at Eγ=662 keV and 60Co with Eγ1=1170 keV and
Eγ2=1330 keV. To avoid signal from electrons in the case of
Cs decays, three copper layers with 350 µm thickness were
inserted in sequence between the source and the probe tip,
and the measurements were repeated at each step. The counts
as measured by the probe are shown in the Fig. 6 for the
three sources. Except for the first measure on the Cs source,
introducing the copper absorbers implies a very small decrease
in rate compatible with the attenuation in copper and the
change in geometrical acceptance.
Fig. 6. Probe sensitivity to photons emitted by three different sources: 60Co
Eγ1=1170 keV Eγ2=1330 keV, 137Cs Eγ=662 keV, 133Ba Eγ ranging from
80 to 350 keV. The measurements were repeated after insertions of copper
layers with thickness of 350 µm between the source and the probe tip to
absorb the electronic component of the Caesium emissions.
The sensitivity to the photons emitted by the 133Ba source
is 0.06%, whereas for the γs from the 137Cs and 60Co sources
the sensitivity is still 0.5%. These measurements allow us to
conclude that the intraoperative β− probe is not sensitive to
the Bremsstrahlung photons and therefore the effectiveness of
the RGS technique would not be affected by this background.
IV. PRECLINICAL TESTS ON SPECIFIC PHANTOMS
A critical aspect in the test of the prototypes for the devel-
opment of the new RGS technique, is the difficulty to perform
realistic studies before the preclinical test. This aspect is
particularly important for this technique because the outcome
of the laboratory test is used to evaluate which clinical cases
to consider. To this aim, specific phantoms were designed
to reproduce finite size meningioma remnants embedded in
healthy brain tissue with a TNR as expected in a real clinical
case, namely meningioma that is considered the test bench of
this technique. The same set-up allows going through different
kinds of interfaces and visual/acoustic feedback to identify
which one could best assist the surgeon in the search for
infected residuals.
A. Realization of the phantoms
The surgical environment is simulated saturating conve-
niently shaped cuttings of a commercially available sponge
(Wettex Classic by Vileda R©) with 90Y-DOTATOC in saline
solution.
The sponge is made of 65% cellulose and 35% cotton fibres
packed as 20×20 cm wide and 2 mm thick dry sheets. The
choice of the sponge was driven by its high water absorbency
(as measured by us on small samples), the ease of obtaining a
sharp and precise cut even with few millimetre wide complex
shapes, and the capability of a sample to regain its original
dimensions after a wetting-drying cycle.
With this technique, both wet or dry surfaces can be
produced depending on the scope of the test: dry phantoms
are used to test the neat physics detector performances (e.g.
sensitivity to active spots, capability of profile reconstruction);
on the contrary, wet surfaces are suitable for studying and
optimizing the probe usage in a more realistic environment
where, for example, tip contamination might occur adding a
random background to the signal coming from the tissues.
The simplest assembly made with this technique is shown in
Fig. 7: a 5 mm diameter circular cutting simulating a 0.05 ml
tumour residual is inserted inside a larger (20 mm diameter)
ring reproducing the nearby healthy tissue. A third round
shape (disk) was eventually used to reproduce the presence of
further healthy tissues above or under the hot spot. Different
TNR between the tumour and the surrounding healthy tissue
were realized drenching the cuttings, up to saturation, with the
properly diluted 90Y solution. The elements were then dried
and combined to shape the topology of interest (Fig. 8).
Fig. 7. Assembling of a phantom simulating a tumour residual of 0.05 ml
embedded in surrounding (the ring) and underneath (the disk) healthy tissue.
Fig. 8. Varying position and activity (white: non-active tissue, yellow:
active tissue) of the assembly elements the discovery potential of the probe
can be tested on surfaces reproducing, even if schematically, some possible
combinations of cancerous residual location and TNR occurring during
surgery.
The nominal activity of any phantom was inferred from
the activity of the 90Y-DOTATOC vial at the time of delivery
and the dilution factor of the bath prepared to drench the
samples. The relative activity of the final dried phantoms was
individually measured before forming the assembly.
B. Active spot identification
A scan over the described assembly was performed by fixing
the probe to a XZ motorized system. The X linear actuator run
the probe over the phantom in 1 mm steps, with a measurement
time of 10 s per position, while the Z actuator was used to set
the tip to surface distance with a precision of 1.5 µm.
The different configurations were analyzed in terms of false-
positive probability (FP), i.e. the probability that the rate
emitted by an healthy tissue is incorrectly flagged by the probe
as tumour residual. In the actual case, this flag will be set
in real time by the system comparing the signal measured
over the tissue under investigation and the patient reference
background previously measured over their healthy tissue.
The probability of false-positive then depends on the probe
efficiency, the time to response and the actual TNR.
An example of a scan is shown in Fig. 9, where the
horizontal lines indicate the minimum rate needed to ensure
FP< 1% with a measurement. Below the figure a scheme of
the source indicates if the individual regions have the activity
associated to background (blue area) or 10 times more (red
area). The unfilled area corresponds to non-active regions. The
device clearly selects the correct region.
Fig. 9. Scan over two assemblies with a probe tip-surface distance next
to zero. The left phantom simulates a 0.5 ml tumour surrounded by a same
thickness healthy tissue with a TNR of 10 (as observed in patients affected
by meningioma), the second assembly is an isolated residual (non-active
surrounding tissue).The full (dashed) line corresponds to the rate needed to
ensure a 1% false positive rate in 1 (10) seconds. See the text for details on
the source representation below the plot.
Fig. 10 and 11 show the same measurement performed
on different tumour-health tissue patterns (fixed the specific
activity and the TNR) that might affect the discovery potential
of the probe.
These evaluations were performed in a neat and well known
configuration, whereas the surgical environment might intro-
duce some perturbations as, for example, a contamination of
the probe tip coming into contact with the wet active tissue.
Such effect can be evaluated directly from the scan shown
in Fig. 9 adding, via software, an extra background to the
measure up to the minimum TNR that makes still detectable
the hot spot. The study lead to the conclusion that the probe is
able to correctly identify the active spot also in case of TNR
as low as 2 with FP = 1% C.L. and a time of measure of
10 s. That means that an eventual contamination would not be
Fig. 10. Scan over two assemblies with a probe tip-surface distance close to
zero realized to study the sensitivity of the probe to a 0.5 ml hot spot masked
by side and beneath emitting (TNR=10) healthy tissue. The full (dashed) line
corresponds to the rate needed to ensure a 1% false positive rate in 1 (10)
seconds. See the text for details on the source representation below the plot.
Fig. 11. Scan over two assemblies with a probe tip-surface distance equal
to zero to test the sensitivity of the probe to a hot spot hidden under an
emitting (TNR=10) healthy tissue. The full (dashed) line corresponds to the
rate needed to ensure a 1% false positive rate in 1 (10) seconds. See the text
for details on the source representation below the plot.
a problem if monitored with frequent background calibration
during the operation.
Moreover, these results imply that the RGS technique with
β− decays would be effective also in case of patients with
a lower TNR compared to those affected by meningioma,
and therefore they are a confirmation that the RGS could be
extended to clinical case of interest with an eventual uptake
of the radiotracer in the nearby healthy organs [8].
C. Minimum detectable tumour residual
A different phantom pattern was used to simulate and
study the evolution of the probe response while removing
an extended tumour area aiming at the identification of the
minimum detectable residual. For this purpose the assembly
shown in Fig. 12 was used. A scan over the whole strip was
repeated reducing the tumoural area by removing a tile at a
time starting from the wider one (5 mm). At each iteration the
Fig. 12. The phantom prepared to simulate the progress of a surgical removal
of a tumour is made by a strip (blue) of 4 tiles of different sizes and charged
at the tumour uptake. A sequence of scans was performed removing a strip
at each iteration to study the minimum detectable residual. At the beginning
and the end of this assembly two tiles (green) ten times less active define the
boundary of the healthy tissue surrounding the tumour.
assembly was packed again to always keep the tumour area
enclosed between healthy tissues.
The scan over the full 15 mm long tumour phantom is
shown in Fig. 13. Following the scan from the right to the
left the experimental shape is read as follow: the cps counts
start from zero (the probe is outside the scanning area) and
increase as the probe goes over the healthy tissue. The small
plateau at 30 cps defines the background level of this measure.
Approaching the tumour phantom, the counts increase up to
plateau at about 250 cps lasting as much as the probe sensitive
area is fully illuminated by the tumour area. As soon as the
sensitive detector exits the last tumour tile the rate goes back
to that of the healthy tissue.
The responses measured reducing the tumour thickness
to 3 mm and 2.5 mm are shown in Fig. 14 and Fig. 15
respectively. In both cases the tumour margins are clearly
identified once the activity of the surrounding healthy tissue
is known.
The smallest residual tested in this measure, obtained re-
ducing by 5 mm the length of the 2.5 mm tile, has a volume
of 0.03 ml. The corresponding signal is shown in Fig. 15.
V. CONCLUSION
We reported on the performances of the first prototype
of the intraoperative probe purposely designed to exploit the
newly proposed radio-guided surgery with β− decays. The
low density and the high light yield of the para-terphenyl
scintillator allow the development of a very compact device
with a good sensitivity to electrons in the range of the 90Y
decays and almost transparent to the bremsstrahlung photons.
The first results obtained experimenting the probe on point-
like and extended 90Y sources highlight the potentiality of this
approach in all the issues relevant in this field: millimetric
remnants discovery potential, spatial resolution, fast response,
dose administered to the patient, operators safety.
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